Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic.

scientific article published on 15 February 2018

Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.PHARMTHERA.2018.02.006
P698PubMed publication ID29454856

P50authorMarián HajdúchQ73099106
P2093author name stringViswanath Das
Khushboo Agrawal
Pankhuri Vyas
P304page(s)45-79
P577publication date2018-02-15
P1433published inPharmacology & TherapeuticsQ3378596
P1476titleNucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic
P478volume188

Reverse relations

cites work (P2860)
Q96945872Cancer Epigenetics, Tumor Immunity, and Immunotherapy
Q90613638Checkpoint inhibitor blockade and epigenetic reprogrammability in CD8+ T-cell activation and exhaustion
Q58787924Differential Regulation of Methylation-Regulating Enzymes by Senescent Stromal Cells Drives Colorectal Cancer Cell Response to DNA-Demethylating Epi-Drugs
Q90266900Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
Q64053420Epigenetics in cancer therapy and nanomedicine
Q91750775Inhibition of Bcl6b promotes gastric cancer by amplifying inflammation in mice
Q93108431MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer
Q64116952Pathological mechanisms and therapeutic outlooks for arthrofibrosis
Q92811214RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy
Q94554680Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21
Q58741597TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma
Q92179985Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
Q91595196The roles of DNA, RNA and histone methylation in ageing and cancer

Search more.